Oxycodone
Moderate-to-severe Chronic Low Back Pain
Egalet LtdSmall moleculePhase 3Dormant
B
63/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 48/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Moderate-to-severe Chronic Low Back Pain cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Oxycodone is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →